Results 1 to 10 of about 549,379 (280)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma [PDF]

Technology in Cancer Research & Treatment, 2021
Purpose: Induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone are both standard treatment regimens for managing locally advanced nasopharyngeal carcinoma. However, the results of comparisons between them in clinical trials vary.
Guoqiang Xu, Qiaoli Wang, Xingrao Wu, Chunyan Lv, Guilin Zeng, Zhihong Xue, Ruixue Cao, Nan Zhang, Wei Xiong, Qin Huang   +9 more
openaire   +4 more sources

Concurrent Chemoradiotherapy for Oropharyngeal Carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials, 2001
The clinical results of definitive chemoradiotherapy for oropharyngeal carcinoma were retrospectively analyzed. Thirty-one patients with oropharyngeal carcinoma who received definitive radiation therapy between January 1986 and June 1998 were analyzed. The median age was 61 years. All patients had squamous cell carcinoma.
Masaki Kokubo, Yasushi Nagata, Yasumasa Nishimura, Hiroyuki Kimura, Kazuhiko Shoji, Ryo Asato, Keisuke Sasai, Masahiro Hiraoka   +7 more
openalex   +4 more sources

Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma [PDF]

International Journal of Radiation Oncology*Biology*Physics, 2008
Extrahepatic cholangiocarcinoma is a rare malignancy. Despite radical resection, survival remains poor, with high rates of local and distant failure. To clarify the role of radiotherapy with chemotherapy, we performed a retrospective analysis of resected patients who had undergone chemoradiotherapy.A total of 45 patients (13 with proximal and 32 with ...
John W. Nelson, A. Paiman Ghafoori, Christopher G. Willett, Douglas S. Tyler, Theodore N. Pappas, Bryan M. Clary, Herbert I. Hurwitz, Johanna C. Bendell, Michael A. Morse, Robert Clough, Brian G. Czito   +10 more
openalex   +3 more sources

A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer

PLOS ONE, 2015
Concurrent chemoradiotherapy is a standard treatment for local advanced esophageal cancer, but the outcomes are controversial. Our goals were to compare the therapeutic effects of concurrent chemoradiotherapy and radiotherapy alone in local advanced esophageal cancer using meta-analysis.MEDLINE, EMBASE and the Cochrane library were searched for studies
Hong Long Ji, Gui Ying Yao, Shi Cong Zhai, Niu Niu Sun, Cui Liu, Ling Yuan, Xiao Jing Li, Li Li Zhu, Xiu-Min Li, Jun Bo Zhang, Hui Wang, Lin Ye, Ling Juan Niu   +12 more
openaire   +3 more sources

Bronchopleural Fistula After Concurrent Chemoradiotherapy [PDF]

Advances in Radiation Oncology, 2020
Jorien M. van de Pas, Lori M. van Roozendaal, Stofferinus L. Wanders, Frank L. Custers, Yvonne L.J. Vissers, Erik R. de Loos   +5 more
openaire   +4 more sources

Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study

Asian Journal of Medical Sciences, 2023
Background: Sequential chemoradiotherapy and concurrent chemoradiotherapy are two treatment options for locally advanced non-small cell lung cancer (NSCLC). Still there is limited data regarding which is the better treatment option.
Subir Pal , Anjan Bera , Soumen Mukherjee , Asmita Dasgupta , Srikrishna Mandal , Saptarshi Banerjee   +5 more
doaj   +1 more source

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma [PDF]

Radiation Oncology, 2020
AbstractBackgroundThis retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and cisplatin in patients with locally advanced esophageal squamous cell carcinoma (ESCC).MethodsPatients with locally advanced ESCC who received CCRT with S-1 (70 mg/m2twice daily on days 1–14 ...
Chang-Hua Yu, Fu-zhi Ji, Yaozu Xiong, Weiguo Zhu, Xi-Lei Zhou, Wanwei Wang, Tong Yusuo   +6 more
openaire   +5 more sources

Survival and toxicity outcomes of induction chemotherapy followed by concurrent chemoradiotherapy compared with concurrent chemoradiotherapy alone in inoperable stage III and IVA/B head and neck cancer

Bangabandhu Sheikh Mujib Medical University Journal, 2022
Concurrent chemoradiotherapy with or without induction chemotherapy is widely practiced in inoperable stage III and IVA/B head and neck cancer. The aim of this study was to investigate the survival and toxicity outcomes of induction chemotherapy ...
Sajib Kumar Talukdhar, Sarwar Alam, Md Abdul Bari, Mohammad Jahan Shams, Md Sohidul Islam, Sadia Sharmin, Md Zillur Rahman Bhuiyan, Md Nazir Uddin Mollah   +7 more
doaj   +1 more source

Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report [PDF]

Journal of Liver Cancer, 2022
There are various methods for treating advanced hepatocellular carcinoma with portal vein invasion, such as systemic chemotherapy, transarterial chemoembolization, transarterial radioembolization, and concurrent chemoradiotherapy.
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim   +5 more
doaj   +1 more source

The Results of Curative Concurrent Chemoradiotherapy for Anal Carcinoma [PDF]

The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2010
Jae-Uk Jeong, Mee Sun Yoon, Ju-Young Song, Sung‐Ja Ahn, Woong-Ki Chung, Byung-Sik Nah, Taek‐Keun Nam   +6 more
openalex   +3 more sources